Dr. Jason C. Sniffen, DO

Dr. Sniffen practices at AdventHealth Orlando in Orlando, Florida, part of AdventHealth.

Dr. Sniffen's NPI, 1982604856, was assigned on July 21, 2005. Dr. Sniffen graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1996. Dr. Sniffen holds Florida license OS7906.

Dr. Sniffen's primary practice is AdventHealth Orlando, at 601 E Rollins St, Orlando, FL 32803 in Orange County. The practice phone is (407) 303-1976.

Dr. Sniffen's primary practice is AdventHealth Orlando in Orlando, Florida, part of AdventHealth. The medical group on file is Infectious Disease Consultants. Dmand AI also links Dr. Sniffen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sniffen practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sniffen's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sniffen is board certified in infectious disease by the AOA Board of Internal Medicine. Dr. Sniffen is licensed in Florida.

CMS data shows 1,961 Medicare services from Dr. Sniffen across 6 procedure codes in 2024, for 491 Medicare patients. Medicare paid $174,673 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 491 Medicare patients who saw Dr. Sniffen in 2024. The largest group is 65 to 74, with 165 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 4.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sniffen's median patient age at 63, with 43% women.

In 2024, Dr. Sniffen wrote 72 Medicare Part D claims for 33 patients. 93% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $529 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sniffen for performance year 2024, reported as part of a group. Dr. Sniffen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Sniffen, published from 2018 to 2023. The most frequent topics are Probiotics, Anti-Bacterial Agents and Clostridioides difficile. Dr. Sniffen has published most often in Clin Infect Dis. Dr. Sniffen's most frequent co-authors are Ellie J.c. Goldstein, MD, Stuart Brian Johnson, MD and Linda J. Bogar, MD.

CMS Open Payments shows 23 general payments to Dr. Sniffen from 10 drug and device companies from 2024 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Melinta Therapeutics, Inc. paid the most, $4,016.

Dmand AI lists 4 awards for Dr. Sniffen, most recently Master Fellow (MACOI) in 2024.

Dr. Sniffen graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1996. Dr. Sniffen is a member of ACOI, ACP and AOA.

Dr. Sniffen is in network with 15 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.